000 01419 a2200373 4500
005 20250513201757.0
264 0 _c20000203
008 200002s 0 0 eng d
022 _a0004-3591
024 7 _a10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAnderson, J J
245 0 0 _aFactors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
_h[electronic resource]
260 _bArthritis and rheumatism
_cJan 2000
300 _a22-9 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntirheumatic Agents
_xtherapeutic use
650 0 4 _aArthritis, Rheumatoid
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMethotrexate
_xtherapeutic use
650 0 4 _aMiddle Aged
650 0 4 _aMultivariate Analysis
650 0 4 _aPlacebos
650 0 4 _aRandomized Controlled Trials as Topic
_xstatistics & numerical data
650 0 4 _aTime Factors
650 0 4 _aTreatment Outcome
700 1 _aWells, G
700 1 _aVerhoeven, A C
700 1 _aFelson, D T
773 0 _tArthritis and rheumatism
_gvol. 43
_gno. 1
_gp. 22-9
856 4 0 _uhttps://doi.org/10.1002/1529-0131(200001)43:1<22::AID-ANR4>3.0.CO;2-9
_zAvailable from publisher's website
999 _c10598935
_d10598935